News for PETVW Stock

Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials DIGITAL LANDIA, LLC IN COOPERATION WITH PETVIVO HOLDINGS, INC. UNVEILS REVOLUTIONARY AUTONOMOUS PET AI ECOSYSTEM TRANSFORMING PET CARE WITH SELF-LEARNING MULTI-AGENT AI TECHNOLOGY  PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERING Petvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal Communication Petvivo Holdings, Inc. to Exhibit at the Western Veterinary Conference in Las Vegas, Nevada PetVivo Reports Fiscal Q3 2025 Results PetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine Products PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024 PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor PetVivo to Exhibit Spryng with OsteoCushion™ Technology at the Veterinary Meeting and Expo Conference in Orlando, Florida on January 25-29, 2025 PETVIVO HOLDING, INC. ANNOUNCES PARTNERSHIP ENGAGEMENTS WITH VEDCO, INC. AND CLIPPER DISTRIBUTING, LLC PETVIVO HOLDINGS, INC. TO HOST SHAREHOLDERS UPDATE MEETING ON JANUARY 8, 2025 PetVivo Holdings, Inc. Announces Participation in The Microcap Conference 2025 PetVivo to Exhibit Spryng with OsteoCushion™ Technology at the American Association of Equine Practitioners Convention on December 8-10, 2024 PetVivo Reports Fiscal Q2 2025 Results PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE SECOND QUARTER ENDED SEPTEMBER 30, 2024 PetVivo Engages Another Top Sales Manager, Cindy Gill, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide PetVivo Taps Top Sales Executive, Skylor Walker, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide PetVivo’s Spryng with OsteoCushion™ Technology Featured in Visionaries on Bloomberg TV PetVivo Meets Growing Demand for Spryng™ with Appointment of Veterinary Surgeon, Kirsty Husby, as Senior Technical Services Veterinarian Scot Cave Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager PetVivo Teams with Orthobiologic Innovations for Clincial Research and Product Commercialization Anthony Germinaro Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager PetVivo Reports Reports Fiscal Q1 2025 Results Eric Samples Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager PetVivo Sets Fiscal First Quarter 2025 Conference Call for Wednesday, August 14 at 5:00 p.m. ET PetVivo Reports Reports Fiscal 2024 Results PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET PetVivo Appoints Former NOVUS and Colgate-Palmolive Senior Sales & Marketing Executive, Bryan Monninger, as VP of Sales April Boyce Joins PetVivo Holdings, Inc. as the Vice President of Marketing PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California PetVivo Holdings, Inc. Approved to Dual List on Upstream PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA PetVivo Reports Third Quarter of Fiscal 2024 Financial Results PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024 PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH COVETRUS NORTH AMERICA, LLC PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng™ in 2023 PetVivo Holdings, Inc. Achieves National Distribution of Spryng™ to More than 600 Veterinary Clinics in 49 States PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, California PetVivo Reports Second Quarter of Fiscal 2024 Financial Results PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE SECOND QUARTER ENDED SEPTEMBER 30, 2023 PetVivo Holdings, Inc. Announces Scheduled Presentations by PetVivo Veterinarians at the American Association of Equine Practitioners Convention in San Diego, California PetVivo Holdings, Inc. Encouraged Over Positive Response Received at 2023 American College of Veterinary Surgeons Conference PetVivo Holdings, Inc. Announces Presentation of Clinical Study Results at the American College of Veterinary Surgeons Conference in Louisville, Kentucky PetVivo Holdings, Inc. to Exhibit at 2023 American College of Veterinary Surgeons Conference PetVivo Holdings Inc. Announces Participation in The ThinkEquity Conference PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE SEPTEMBER 11-13, 2023 PetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 500 Veterinary Clinics in 49 States PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application PetVivo Reports First Quarter of Fiscal 2024 Financial Results PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE FIRST QUARTER ENDED June 3, 2023 PetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 450 Veterinary Clinics PETVIVO HOLDINGS, INC. ANNOUNCES RESCHEDULED EARNINGS CALL FOR THE YEAR ENDED MARCH 31, 2023 PetVivo Reports Fiscal 2023 Full Year Financial Results Dr. Jeremy Caplin Joins PetVivo Holdings, Inc. as the Director of Research PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2023 ENDED MARCH 31, 2023 PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human Indication Dr. Thomas Yarbrough Joins PetVivo Holdings, Inc. as the Senior Research Director Dr. Maureen Dower Joins PetVivo Holdings, Inc. as a Senior Technical Services Veterinarian Trina Lally Joins PetVivo Holdings, Inc. as the Northeast Business Development Manager PETVIVO HOLDINGS, INC. TO PRESENT AT AEGIS CAPITAL VIRTUAL CONFERENCE ON MAY 2-4, 2023 Mary Grace Rutland Joins PetVivo Holdings, Inc. as the Mid-Atlantic Business Development Manager PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA Spencer Breithaupt Joins PetVivo Holdings, Inc. Board of Directors PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN ATLANTA, GEORGIA  Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Big Sky, Montana PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos Veterinary Health to Present Canine Study Results at the Veterinary Orthopedic Society Annual Conference PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA PetVivo Reports Third Quarter of Fiscal 2023 Financial Results PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2022 PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE MINNESOTA VETERINARY MEDICAL ASSOCIATION ANNUAL MEETING IN MINNEAPOLIS, MINNESOTA PETVIVO HOLDINGS, INC. TO PARTICIPATE IN THE LYTHAM PARTNERS INVESTOR SELECT CONFERENCE PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 44TH LAKE TAHOE EQUINE CONFERENCE IN INCLINE VILLAGE, NEVADA  PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 2023 OCALA EQUINE CONFERENCE IN OCALA, FLORIDA PETVIVO HOLDINGS, INC. ANNOUCES PLAN FOR NEW MANUFACTURING FACILITY PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA PetVivo Holdings, Inc. Announces Application for Dual Listing on Upstream PetVivo Holdings, Inc. to Present at Sequire Virtual Small Cap Conference on December 8th, 2022 PetVivo Reports Second Quarter of Fiscal 2023 Financial Results PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Antonio, Texas PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR SECOND QUARTER ENDED September 30, 2022 PETVIVO HOLDINGS, INC. TO PRESENT AT LD MICRO MAIN EVENT XV PETVIVO HOLDING, INC. ANNOUNCES SPRYNG™ NOW AVAILABLE TO VETERNARIANS THROUGH MWI ANIMAL HEALTH Paula Wittler Joins PetVivo Holdings, Inc. as the Western Business Development Manager PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE SEPTEMBER 12-14, 2022 PetVivo Reports First Quarter of Fiscal 2023 Financial Results Leslie Coolidge and Rob Costantino Join PetVivo Holdings, Inc. Board of Directors PetVivo Holdings, Inc. Announces Formation of Nonprofit PetVivo Cares To Advance The Health & Well-Being of Companion Animals PetVivo to Discuss Financial Results for the Fiscal Year End ended March 31, 2022 and Business Update PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI ANIMAL HEALTH PETVIVO HOLDINGS, INC. TO PROVIDE COMPANY UPDATE RELATED TO THE MWI DISTRIBUTION AGREEMENT AND DISCUSS RESULTS FOR THE FISCAL YEAR ENDED MARCH 31, 2022 PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2022 ENDED MARCH 31, 2022 PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. Wainwright Global Investment Conference May 23-26, 2022 Petvivo Holdings, Inc. To Present at the Planet Microcap Showcase 2022 in Las Vegas Rachael Schumaker Joins PetVivo Holdings, Inc. as the Midwest Business Development Manager David J. Gregory Joins PetVivo Holdings, Inc. as the Regional Sales Manager Cliff Smith Joins PetVivo Holdings, Inc. as the Regional Sales Manager PETVIVO HOLDINGS, INC. ANOUNCES LAUNCH OF NEW COMPANY AND PRODUCT WEBSITES PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA PetVivo Reports Third Quarter 2022 Financial Results PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THIRD QUARTER ENDED DECEMBER 31, 2021 [UPDATED] PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THIRD QUARTER ENDED DECEMBER 31, 2021 PetVivo Holdings to Present at Emerging Growth Conference on January 19, 2022 PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA PETVIVO HOLDINGS, INC. ANNOUNCES DISTRIBUTION OF ITS VETERINARY MEDICAL DEVICE, SPRYNG™, BY VETCOVE, INC. PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 2022 BioConnect Conference January 10-13, 2022 (VIRTUAL CONFERENCE) PetVivo Holdings, Inc. exhibits at American Association of Equine Practitioners Conference in Nashville, TN PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in Nashville, Tennessee PETVIVO HOLDINGS, INC. LAUNCHES DIGITAL MEDIA CAMPAIGN PetVivo Reports Second Quarter 2022 Financial Results - Updated PetVivo Reports Second Quarter 2022 Financial Results PETVIVO HOLDINGS, INC. TO ANNOUNCE SECOND QUARTER 2022 RESULTS PetVivo Holdings Announces Closing of Public Offering and Nasdaq Listing PetVivo Holdings Announces Pricing of Public Offering and Nasdaq Listing